Regulation of antigen-specific T cell infiltration and spatial architecture in multiple myeloma and premalignancy-Reference-Cited by-同舟云学术

Regulation of antigen-specific T cell infiltration and spatial architecture in multiple myeloma and premalignancy

Published:2023-08-01 Issue:15 Volume:133 Page:
ISSN:1558-8238
Container-title:Journal of Clinical Investigation
language:en
Short-container-title:

Author:

Robinson M. Hope^ORCID,Villa Nancy Y.,Jaye David L.^ORCID,Nooka Ajay K.^ORCID,Duffy Alyssa^ORCID,McCachren Samuel S.^ORCID,Manalo Julia,Switchenko Jeffrey M.^ORCID,Barnes Sierra,Potdar Sayalee^ORCID,Azeem Maryam I.,Horvat Ava A.,Parihar Vaunita C.,Gong Jingjing^ORCID,Liang Yan^ORCID,Smith Geoffrey H.^ORCID,Gupta Vikas A.^ORCID,Boise Lawrence H.^ORCID,Kaufman Jonathan L.^ORCID,Hofmeister Craig C.^ORCID,Joseph Nisha S.,Lonial Sagar,Dhodapkar Kavita M.^ORCID,Dhodapkar Madhav V.

Funder

NCI

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Link

https://www.jci.org/articles/view/167629/files/pdf

Reference39 articles.

1. Tumor-Infiltrating T Cells — A Portrait

2. MGUS to myeloma: a mysterious gammopathy of underexplored significance

3. Vigorous Premalignancy-specific Effector T Cell Response in the Bone Marrow of Patients with Monoclonal Gammopathy

4. T cells from the tumor microenvironment of patients with progressive myeloma can generate strong, tumor-specific cytolytic responses to autologous, tumor-loaded dendritic cells

5. The immune system in multiple myeloma and precursor states: lessons and implications for immunotherapy and interception;Dhodapkar;Am J Hematol,2022

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Understanding CAR-T therapy in myeloma: 1 cell at a time;Blood Advances;2024-07-09

2. Topological importance of CD8 + T-cell enrichment in the tumor microenvironment of classic Hodgkin lymphoma;2024-06-10

3. Impact of extramedullary multiple myeloma on outcomes with idecabtagene vicleucel;Journal of Hematology & Oncology;2024-06-06

4. Immune status and selection of patients for immunotherapy in myeloma: a proposal;Blood Advances;2024-05-20

5. T-Cell Characteristics Impact Response and Resistance to T-Cell–Redirecting Bispecific Antibodies in Multiple Myeloma;Clinical Cancer Research;2024-04-30